The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells-Reference-Cited by-同舟云学术

The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells

Published:2020-11-07 Issue:1 Volume:11 Page:188-196
ISSN:2228-5881
Container-title:Advanced Pharmaceutical Bulletin
language:en
Short-container-title:Adv Pharm Bull

Author:

Meiyanto Edy¹²^ORCID,Husnaa Ulfatul¹,Kastian Ria Fajarwati¹^ORCID,Putri Herwandhani¹,Larasati Yonika Arum¹^ORCID,Khumaira Annisa¹,Pamungkas Dyaningtyas Dewi Putri¹³,Jenie Riris Istighfari¹²^ORCID,Kawaichi Masashi⁴⁵,Lestari Beni¹^ORCID,Yokoyama Takashi⁶,Kato Jun-ya⁶

Affiliation:

1. Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281 Indonesia.

2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281 Indonesia.

3. Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281 Indonesia.

4. Graduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630- 0192, Japan.

5. Division of Educational Development, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630- 0192, Japan.

6. Laboratory of Tumor Cell Biology, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara, 630-0101, Japan.

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Link

https://apb.tbzmed.ac.ir/PDF/apb-11-188.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the genetic landscape: high frequency of pik3ca mutation in luminal a and b breast cancer within the Indonesian population;2024-06-03

2. Diosmin Enhances the Anti-migration Activity of Curcumin Analog PGV-1 on Colorectal Cancer Cells;The Indonesian Biomedical Journal;2024-02-23

3. Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities: in vitro and in vivo studies;Saudi Pharmaceutical Journal;2024-01

4. The Synergistic Cytotoxic Effect of Pentagamavunon-1 (PGV-1) and Curcumin Correlates with the Cell Cycle Arrest to Induce Mitotic Catastrophe in 4T1 and T47D Breast Cancer Cells;The Indonesian Biomedical Journal;2023-10-18

5. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells;Journal of the Egyptian National Cancer Institute;2023-03-27